Physician profile
Jeff Chao
NPI 1619673449
$1,215.00
in general payments reported to CMS, 2019-2025
11 companies · $67.59 in 2025
The $67.59 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $503 · 2024: $645 · 2025: $67.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,215.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $522.88 | 2023-2025 | Rexulti |
| Teva Pharmaceuticals USA, INC. | $155.74 | 2024 | Uzedy, Austedo Xr |
| Almatica Pharma LLC | $110.56 | 2023-2024 | Loreev Xr, Sertraline Hcl |
| Takeda Pharmaceuticals U.S.A., INC. | $90.40 | 2023-2024 | Trintellix |
| Corium, LLC | $89.74 | 2023-2024 | Azstarys |
| Bausch Health US, LLC | $82.45 | 2023-2024 | Wellbutrin, Aplenzin |
| Axsome Therapeutics, INC. | $56.31 | 2023-2024 | Auvelity |
| Neos Therapeutics, LP | $39.82 | 2024 | Adzenys Xr-Odt |
| Abbvie INC. | $28.85 | 2023 | |
| Alkermes, INC. | $24.25 | 2024 | Aristada, Lybalvi |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $14.00 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeff Chao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.